[HTML][HTML] How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review
D Kwaśniewska, M Fudalej, P Nurzyński… - Cancers, 2023 - mdpi.com
Simple Summary Recently observed improvement in the treatment of pancreatic ductal
adenocarcinoma (PDAC) has resulted mainly from improved perioperative care and more …
adenocarcinoma (PDAC) has resulted mainly from improved perioperative care and more …
How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review.
D Kwaśniewska, M Fudalej, P Nurzyński… - …, 2023 - search.ebscohost.com
Abstract Simple Summary: Recently observed improvement in the treatment of pancreatic
ductal adenocarcinoma (PDAC) has resulted mainly from improved perioperative care and …
ductal adenocarcinoma (PDAC) has resulted mainly from improved perioperative care and …
How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review
D Kwaśniewska, M Fudalej, P Nurzyński… - …, 2023 - search.proquest.com
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with high morbidity
and mortality in which long-term survival rates remain disastrous. Surgical resection is the …
and mortality in which long-term survival rates remain disastrous. Surgical resection is the …
[HTML][HTML] How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review
D Kwaśniewska, M Fudalej, P Nurzyński… - Cancers, 2023 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with high morbidity
and mortality in which long-term survival rates remain disastrous. Surgical resection is the …
and mortality in which long-term survival rates remain disastrous. Surgical resection is the …
How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated-A Comprehensive Review.
D Kwaśniewska, M Fudalej, P Nurzyński… - Cancers, 2023 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with high morbidity
and mortality in which long-term survival rates remain disastrous. Surgical resection is the …
and mortality in which long-term survival rates remain disastrous. Surgical resection is the …
[PDF][PDF] How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review. Cancers 2023, 15, 4275
D Kwasniewska, M Fudalej, P Nurzynski… - 2023 - pdfs.semanticscholar.org
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with high morbidity
and mortality in which long-term survival rates remain disastrous. Surgical resection is the …
and mortality in which long-term survival rates remain disastrous. Surgical resection is the …
How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated-A Comprehensive Review
D Kwaśniewska, M Fudalej, P Nurzyński… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with high morbidity
and mortality in which long-term survival rates remain disastrous. Surgical resection is the …
and mortality in which long-term survival rates remain disastrous. Surgical resection is the …